Skip to content

Archipelago of Ovarian Cancer Research

Archipelago of Ovarian Cancer Research: a nationwide, interdisciplinary infrastructure, including a national biobank, to promote and coordinate fundamental and translation research on ovarian cancer in the Netherlands

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON26124
Enrollment
32500
Registered
2020-04-14
Start date
2020-10-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian cancer, Fallopian tube cancer and primary peritoneal cancer.

Interventions

None listed

Sponsors

Dutch Cancer Society
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Suspected or diagnosed ovarian cancer, Fallopian tube cancer or primary peritoneal cancer; • Age =16 years; • Written informed consent.

Exclusion criteria

Exclusion criteria: • Mental disabilities; • Not able to understand the patient information.

Design outcomes

Primary

MeasureTime frame
Improved diagnostics, treatment and survival

Secondary

MeasureTime frame
Identification of predictive and prognostic factors

Contacts

Public ContactFrederike Dijk

Amsterdam University Medical Center, location Academic Medical Center

f.dijk@amsterdamumc.nl+31 (0)20 566 56 45

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)